A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABL1 | ABL proto-oncogene 1, non-receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ACLY | ATP citrate lyase | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACO1 | Aconitase 1, soluble | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADNP | Activity-dependent neuroprotector homeobox | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
AHR | Aryl hydrocarbon receptor | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AKAP12 | A kinase (PRKA) anchor protein 12 | Cancer-related genes Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALDOA | Aldolase A, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALDOC | Aldolase C, fructose-bisphosphate | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AMPH | Amphiphysin | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
ANGPT1 | Angiopoietin 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
ANK3 | Ankyrin 3, node of Ranvier (ankyrin G) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ANXA11 | Annexin A11 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ANXA4 | Annexin A4 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
APOA2 | Apolipoprotein A-II | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC1 | Apolipoprotein C-I | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ATM | ATM serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
AXIN2 | Axin 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |